A Rare Case of Renal Vein Thrombosis Secondary to Oral Contraceptive Pills.

Renal vein thrombosis (RVT) is a common complication of nephrotic syndrome and renal malignancy. However, its association with oral contraceptive use has rarely been reported. We report a case of a 29-year-old female with a history of oral contraceptive use, presenting with acute flank pain. On further investigation, she was found to have unilateral RVT. Oral contraception was discontinued, and she was started on therapeutic anticoagulation, initially with low-molecular-weight heparin, and then switched to apixaban. Her symptoms improved, and she is currently doing well. This case signifies the importance of proper history-taking and how oral contraception should be considered a significant risk factor for venous thromboembolism.

Anticoagulation for left ventricular thrombi secondary to COVID-Is 3 months too long?

The length of anticoagulation for thrombotic events related to COVID-19 is unknown. We present a patient with COVID-19 complicated by a thrombotic anterior STEMI and multiple left ventricular (LV) thrombi that resolved after 8 weeks of anticoagulation. We suggest a shorter length of anticoagulation with COVID-19-related LV thrombus.

A Case of Aortic Valve Infective Endocarditis with Dermatological Findings of Infective Endocarditis.

Infective endocarditis (IE) is associated with high morbidity and mortality. We present a case of a patient that presented with chest pain and had a workup focused on coronary artery disease and acute coronary syndrome. However, the patient had a history and, even more interestingly, physical exam findings, including Janeway lesions, Osler's nodes, and Splinter hemorrhages, indicative of infective endocarditis. We are sharing the findings that raised our suspicion for IE and a discussion on the pathophysiology of these findings in an effort to promote early recognition and treatment of IE.